Market Overview

22 Stocks Moving In Monday's Pre-Market Session

Share:

Gainers

  • La Jolla Pharmaceutical Company (NASDAQ: LJPC) rose 47.6 percent to $29.32 in pre-market trading as the company disclosed that ATHOS-3 Phase 3 efficacy endpoint is statistically significant.
  • VOXX International Corp (NASDAQ: VOXX) shares rose 9.5 percent to $4.60 in pre-market trading. EyeLock LLC, a subsidiary of Voxx, disclosed that it will demonstrate its elite iris biometric solution on the Qualcomm® Snapdragon™ 835 mobile platform at Mobile World Congress 2017
  • Zhaopin Ltd (ADR) (NYSE: ZPIN) shares rose 9 percent to $19.58 in pre-market trading after gaining 4.53 percent on Friday.
  • Sangamo Therapeutics Inc (NASDAQ: SGMO) rose 7.5 percent to $4.30 in pre-market trading after the company disclosed that it has received rare pediatric disease designation from the FDA for SB-318.
  • Gogo Inc (NASDAQ: GOGO) shares rose 7.4 percent to $9.79 in pre-market trading after the company reported a narrower-than-expected quarterly loss.
  • Cempra Inc (NASDAQ: CEMP) rose 7.3 percent to $4.34 in pre-market trading after surging 28.57 percent on Friday.
  • AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) rose 6.7 percent to $3.20 in pre-market trading as the company announced that the NDA for Dsuvia has been accepted for filing with PDUFA date of October 12th.
  • Owens Corning (NYSE: OC) rose 5.9 percent to $61.14 in pre-market trading after declining 0.45 percent on Friday.
  • Insys Therapeutics Inc (NASDAQ: INSY) shares rose 5.2 percent to $12.65 in pre-market trading after dropping 6.02 percent on Friday.
  • Inovio Pharmaceuticals Inc (NASDAQ: INO) rose 4.2 percent to $6.96 in pre-market trading after declining 3.19 percent on Friday.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

  • BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) fell 15.5 percent to $4.64 in pre-market trading. BioCryst posted a Q4 loss of $0.06 per share on revenue of $8.98 million and reported that its interim results from APeX-1 trial are 'positive.'
  • Nova Lifestyle Inc (NASDAQ: NVFY) fell 9.7 percent to $2.04 in pre-market trading after tumbling 9.96 percent on Friday.
  • KEMET Corporation (NYSE: KEM) dropped 9.1 percent to $10.00 in pre-market trading after rising 5.77 percent on Friday.
  • DryShips Inc. (NASDAQ: DRYS) shares fell 9 percent to $2.04 in pre-market trading after dropping 4.68 percent on Friday.
  • Spark Energy Inc (NASDAQ: SPKE) shares fell 8.3 percent to $25.00 in pre-market trading after surging 6.65 percent on Friday.
  • Sun Communities Inc (NYSE: SUI) fell 5.9 percent to $78.61 in pre-market trading after rising 1.46 percent on Friday.
  • Perion Network Ltd (NASDAQ: PERI) fell 5.2 percent to $2.01 in pre-market trading after rising 0.95 percent on Monday.
  • Urban Outfitters, Inc. (NASDAQ: URBN) fell 3.3 percent to $26.00 in pre-market trading. MKM Partners downgraded Urban Outfitters from Neutral to Sell.
  • Harmony Gold Mining Co. (ADR) (NYSE: HMY) fell 3 percent to $2.59 in pre-market trading after declining 3.44 percent on Friday.
  • StoneMor Partners L.P. (NYSE: STON) fell 3 percent to $9.78 in pre-market trading. StoneMor Partners disclosed that it will delay 10K and conference call due to underreported cemetery revenue and over reported deferred revenue.
  • Tesla Inc (NASDAQ: TSLA) shares fell 2.6 percent to $250.25 in pre-market trading. Goldman Sachs downgraded Tesla from Neutral to Sell and lowered the price target from $190.00 to $185.00.
  • JinkoSolar Holding Co., Ltd. (NYSE: JKS) fell 2.2 percent to $16.77 in pre-market trading. JinkSolar posted Q4 earnings of $1.04 per share on revenue of $737.6 million.

Posted-In: #PreMarket Gainers LosersNews Movers & Shakers Pre-Market Outlook Markets Movers

 

Related Articles (BCRX + ACRX)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

China ETFs Assert Some Leadership

Expect A Pair Of Drug Approvals From BioMarin In 2017; Stock Remains Pricey